Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E. Ordóñez JL, et al. Among authors: rodrigues t. Oncotarget. 2015 Aug 7;6(22):18875-90. doi: 10.18632/oncotarget.4303. Oncotarget. 2015. PMID: 26056084 Free PMC article.
Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, García-Macías MDC, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E. Ordóñez JL, et al. Among authors: rodrigues t. Oncotarget. 2017 Jun 27;8(26):43592. doi: 10.18632/oncotarget.18610. Oncotarget. 2017. PMID: 28672777 Free PMC article. No abstract available.
Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region.
Naveca FG, Almeida TAP, Souza V, Nascimento V, Silva D, Nascimento F, Mejía M, Oliveira YS, Rocha L, Xavier N, Lopes J, Maito R, Meneses C, Amorim T, Fé L, Camelo FS, Silva SCA, Melo AX, Fernandes LG, Oliveira MAA, Arcanjo AR, Araújo G, André Júnior W, Carvalho RLC, Rodrigues R, Albuquerque S, Mattos C, Silva C, Linhares A, Rodrigues T, Mariscal F, Morais MA, Presibella MM, Marques NFQ, Paiva A, Ribeiro K, Vieira D, Queiroz JADS, Passos-Silva AM, Abdalla L, Santos JH, Figueiredo RMP, Cruz ACR, Casseb LN, Chiang JO, Frutuoso LV, Rossi A, Freitas L, Campos TL, Wallau GL, Moreira E, Lins Neto RD, Alexander LW, Sun Y, Filippis AMB, Gräf T, Arantes I, Bento AI, Delatorre E, Bello G. Naveca FG, et al. Among authors: rodrigues t. Nat Med. 2024 Sep 18. doi: 10.1038/s41591-024-03300-3. Online ahead of print. Nat Med. 2024. PMID: 39293488
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, Čelutkienė J, Zdravkovic M, Bielecka-Dabrowa AM, Agostoni P, Xuereb RG, Neronova KV, Lelonek M, Cavusoglu Y, Gellen B, Abdelhamid M, Hammoudi N, Anker SD, Chioncel O, Filippatos G, Lainscak M, McDonagh TA, Mebazaa A, Piepoli M, Ruschitzka F, Seferović PM, Savarese G, Metra M, Rosano GMC, Maggioni AP; ESC EORP HF III National Leaders and Investigators. Lund LH, et al. Eur J Heart Fail. 2024 Sep 10. doi: 10.1002/ejhf.3445. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39257278
1,126 results